Authors : Apiyanteide F; Chiroma U; Orjingene O; Joseph O

Volume/Issue : Volume 10 - 2025, Issue 4 - April

Google Scholar : https://tinyurl.com/franbyrx

Scribd : https://tinyurl.com/4b8j5sn4

DOI : https://doi.org/10.38124/ijisrt/25apr1755

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.

Abstract : Meningitis is a deadly disease that poses profound public health threats and responsible for outbreaks and death of children mainly in the meningitis belt of Africa. This study was designed to determine the effectiveness of mass vaccination against Meningitis in Yobe State, Northeast Nigeria. An ecological study design involving the collection of secondary data from Yobe State Epidemiological unit based on the Integrated Disease Surveillance Response System template was done. The outcomes measured include the morbidity and mortality from meningitis across all the local government areas in Yobe State. This involved the collection of all the meningitis cases that were reported within the period under review (2017-2018). A comparative analysis of the morbidity and mortality from meningitis before (pre) and after (post) mass vaccination against the disease was made. The mass vaccination intervention was conducted within the first week of February 2018 and the effects of this intervention was measured. A paired sample t-test was done using the Statistical Package for Social Sciences (SPSS) windows version 22 to determine the relationship between mass vaccination and morbidity and mortality from meningitis. Result revealed that a total of 480 cases were reported during the study period, 415(86.5%) in 2017 (pre mass vaccination and 65(13.5%) were reported in 2018 (post vaccination). 53 deaths out of the 480 total number of cases were recorded and the Case Fatality Rate (CFR) = 11.04% was estimated during the study. Majority 43(81.13) of the deaths occurred in 2017 while the remaining 10(18.87) were reported in 2018 when mass vaccination against meningitis was conducted. Mass vaccination resulted in a 72.9% decline in the number of cases and a 62.3% decline in the number of deaths from meningitis in Yobe State during the study period. There was a statistically significant difference in the number of cases of meningitis before (pre) and after (post) the mass vaccination. Mean 12.5, (95% CI: -5.892 to 30.892) with alpha set at 0.05, P = 0.045. However, there was no statistically significant difference in the number of deaths associated with meningitis, Mean 2.750, (95% CI: -2.097 to 7.597) with alpha set at 0.05, P = 0.646. Mass vaccination against meningitis therefore confers herd immunity to populations with a subsequent significant decline in morbidity associated with the infection. It is therefore important for mass vaccination against meningitis to be intensified in order to control, possibly eliminate and eradicate the disease in Sub-Saharan Africa with a high burden of the infection in the meningitis belt.

Keywords : Effects, Meningitis, Meningococal Vaccine, Mass Vaccination, Immunization.

References :

1. Abdussalam, A.F., Monaghan, J.A.,  Dukic, M.V. Hayden, M.R., Hopson, M.T., John, T. & Leckebusch, G.C.. (2014). The Impact of Climate Change on Meningitis in Northwest Nigeria: An Assessment Using CMIP5 Climate Model Simulations. Climate, Weather, and Society. 10.1175/WCAS-D-13-00068.1.
2. Ajibola, O., Omoleke, S.A., & Omishakin, O.A. (2018). Current status of cerebrospinal meningitis and impact of the 2015 meningococcal C vaccination in Kebbi, Northwest Nigeria. Vaccine 36(11):1423-1428.
3. Andersen, J., Backer, V., & Voldsgaard, P. (1997). Acute meningococcal meningitis: analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group. J Infect. 34(3):227-35.
4. Andrade, A.L., Minamisava, R., Tomich, L.M., Lemos, A.P., Gorla, M.C., de Cunto Brandileone, M.C., Domingues, C.M.S., de Moraes, C., Policena, G., & Bierrenbach, A.L. (2017). Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil. Vaccine. 35(16):2025-2033.
5. Antai, D. (2009). Inequitable childhood immunization uptake in Nigeria: a multilevel analysis of individual and contextual determinants. BMC Infectious Diseases. 9, 181.
6. Artenstein, W.A. (2010). Vaccines: A Biography. Springer New York Dordrecht Heidelberg London. Pp. 1-8.
7. Barrett, A.D. (2015). Vaccinology : an essential guide. John Wiley & Sons. p. 168. ISBN 9780470656167.
8. Borrow, Alarcon, Carlos and Caugant et al (2017). The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev Vaccines 16(4):313-328
9. Dodet, B., Korejwo, J. & Briggs, D.J. (2013). Eliminating the scourge of dog-transmitted rabies. Vaccine. 31(10):1359.
10. Hassan, A., Mustapha, G.U., Lawal, B.B., Na’uzo, A.M., Ismail, R., Womi-Eteng Oboma, E., et al. (2018). Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria – 2017. PLoS ONE 13(6): e0199257. https://doi.org/10.1371 /journal.pone.0199257.
11. MacDonald, N.E., Harmon, S. & Dube, E., et al. (2018). Mandatory infant & childhood immunization: rationales, issues and knowledge gaps. Vaccine. 3:5811–5818.
12. Mohammed, I., Obineche, E.N. Onyemelukwe, G.C. & Zaruba, K. (1984): Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria. J Infect. 9(2):190-6.
13. Moloo, H., & Artenstein, A.W. (2008). History of vaccines. In: Encyclopedia of Public Health. Murray CJ (Ed.). Elsevier.
14. National Population Commission (NPC) [Nigeria], & ICF International. (2014). Nigeria demographic health survey. Abuja, Nigeria and Rockville.
15. Nigeria Centre for Disease Control (NCDC, 2019). Meningitis. Available at: https://ncdc.gov.ng/dise ases/factsheet/49. Accessed, July, 2021.
16. Nnadi, C., Oladejo, J., Yennan, S., Ogunleye, A., Agbai, C., Bakare, L., Abdulaziz, M., Mohammed, A., Stephens, M., Sumaili, K., Ronveaux, O., Maguire, H., Karch, D., Dalhat, M., Antonio, M., Bita, A., Okudo, I., Nguku, P., Novak, R., Bolu, O., Shuaib, F., & Ihekweazu, C. (2017). Large Outbreak of Neisseria meningitidis Serogroup C - Nigeria, December 2016-June 2017. MMWR Morb Mortal Wkly Rep. 15;66(49):1352-1356. doi: 10.15585/mmwr.mm6 649a3.
17. Ophori, E.A., Tula, M.Y., Azih, A.V., Okojie, R., & Ikpo, P.E. (2014). Current trends of immunization in Nigeria: prospect and challenges. Trop Med Health. 42(2):67-75. doi: 10.2149/tmh.2013-13.
18. Parish, H.J. (1965).  A History of Immunization. E & S Livingstone Ltd, Edinburgh, UK. 
19. Stefanelli, P., & Rezza, G. (2016). Impact of vaccination on meningococcal epidemiology. Human vaccines & immunotherapeutics, 12(4), 1051–1055.
20. Theodoridou, M.N., Vasilopoulou, V.A., Atsali, E.E., Pangalis, A.M., Mostrou, G.J., Syriopoulou, V.P., & Hadjichristodoulou, C.S. (2007). Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. BMC Infect Dis. 7:101. doi: 10.1186/1471-2334-7-101.
21. Tsai, C. J., Griffin, M. R., Nuorti, J. P., & Grijalva, C. G. (2008). Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clinical infectious diseases. Infectious Diseases Society of America, 46(11), 1664–1672.
22. United Nations International Children’s Emergency Fund (UNICEF, 2018). Immunization summary. A statistical referencing containing immunization data
23. Woods, C.W., Armstrong, G., Sackey, S.O., Tetteh, C., Bugri, S., Perkins, B.A., & Rosenstein, N.E. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa. Lancet, 355(9197):30-3.
24. World Health Organization (2014). Meningitis outbreak response in sub-Saharan Africa. WHO guideline. Geneva, Switzerland: World Health Organization; 2014. Available at: http://www.who.int/csr/resources/publications/meningitis/ guidelines2014/en/ [PubMed]. Accessed, July, 2021.
25. World Health Organization (2017). Addressing Vaccine Hesitancy. Secondary Addressing Vaccine Hesitancy. Available at http://www.who.int/ immunization/programmes_systems/vaccine_hesitancy/en/.
26. World Health Organization (WHO, 2011). Meningococal Vaccines: WHO position paper. Weekly Epidemiological Record, 86(47):521-540.
27. World Health Organization (WHO, 2018). Immunization, Vaccines and Biologicals; Immunization Coverage Cluster Survey - Reference manual; WHO/IVB/04.23.